The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 11, 2018
Filed:
Jan. 29, 2014
Applicants:
Nitto Denko Corporation, Osaka, JP;
Osaka University, Osaka, JP;
Inventors:
Katsuyuki Okubo, Osaka, JP;
Yoshiki Maeda, Osaka, JP;
Arimichi Okazaki, Osaka, JP;
Daisuke Asari, Osaka, JP;
Takuya Shishido, Osaka, JP;
Mitsuhiko Hori, Osaka, JP;
Haruo Sugiyama, Osaka, JP;
Assignees:
NITTO DENKO CORPORATION, Osaka, JP;
OSAKA UNIVERSITY, Osaka, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 38/10 (2006.01); A61K 39/00 (2006.01); A61K 31/045 (2006.01); A61K 31/437 (2006.01); A61K 31/451 (2006.01); A61K 31/513 (2006.01); A61K 31/708 (2006.01); A61K 31/716 (2006.01); A61K 31/728 (2006.01); A61K 31/739 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0014 (2013.01); A61K 31/045 (2013.01); A61K 31/437 (2013.01); A61K 31/451 (2013.01); A61K 31/513 (2013.01); A61K 31/708 (2013.01); A61K 31/716 (2013.01); A61K 31/728 (2013.01); A61K 31/739 (2013.01); A61K 38/10 (2013.01); A61K 39/0011 (2013.01); A61K 2039/54 (2013.01);
Abstract
The present invention provides a cancer vaccine composition for transdermal administration for cellular immunity induction, comprising (i) a WT1 peptide and/or a modified WT1 peptide; and (ii) a pharmacologically acceptable acid as a first cellular immunity induction promoter, or a pharmacologically acceptable salt thereof.